CHARMed collaboration creates a potent therapy candidate for fatal prion diseases
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.
Fifteen new faculty members join six of the school’s academic departments.
Guoping Feng, Piotr Indyk, Daniel Kleitman, Daniela Rus, Senthil Todadri, and nine alumni are recognized by their peers for their outstanding contributions to research.
By providing plausible label maps for one medical image, the Tyche machine-learning model could help clinicians and researchers capture crucial information.
The junior, who is majoring in computer science and molecular biology, wants to “make it a norm to lift others as I continue to climb.”
Moved by the human devastation and scientific conundrum of Alzheimer’s, William Li seeks to work on therapies for the disease.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
Fellows honored for creativity, innovation, and research accomplishments.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.